Literature DB >> 7007220

The conversion of an enhancing factor to a suppressor factor by the formation of an aggregate molecule.

H L Mulcahy, A S Rubin, A B MacDonald.   

Abstract

A non-specific suppressor factor, owl monkey suppressor factor, OMSF, from leukaemic owl monkey peripheral T lymphocytes has been isolated and characterized. OMSF is a glycoprotein of a molecular weight of 66,000 which can be produced from purified owl monkey enhancing factor, OMEF, by both Tris buffer dialysis and by repeated freezing and thawing. SDS gel electrophoresis demonstrates that OMSF is composed of 39,000 mol. wt subunits which co-migrate with the OMEF molecule. This suppressor acts at less than nanogram levels on day 0 of the in vitro immune response to suppress the number of plaque-forming cells produced to sheep red blood cells in a murine assay system and has little effect when added on day 2 to this system. OMSF is bound by antibodies raised specifically against OMEF and inhibits the binding of OMEF to this antiserum in a competitive radioimmunoassay. These results suggest that both enhancement and suppression of the immune response can be mediated by the same molecule under different circumstances.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7007220      PMCID: PMC1458203     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Regulation of the immune response: production of a soluble suppressor by immune spleen cells in vitro.

Authors:  D W Thomas; W K Roberts; D W Talmage
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

Review 2.  Thymus-independent B-cell induction and paralysis.

Authors:  A Coutinho; G Möller
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

3.  Interconversion of horse heart cytochrome C monomer and polymers.

Authors:  E MARGOLIASH; J LUSTGARTEN
Journal:  J Biol Chem       Date:  1962-11       Impact factor: 5.157

4.  Transient suppression of the humoral immune response mediated by a factor derived from specifically activated, doubly primed lymphoid cells.

Authors:  K E Kempf; A S Rubin
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

5.  The role of histocompatibility gene products in lymphocyte triggering and differentiation.

Authors:  D H Katz; D Armerding
Journal:  Fed Proc       Date:  1976-07

6.  Current concepts of the antibody response: heterogeneity of lymphoid cells, interactions, and factors.

Authors:  M Feldmann; P Beverley; P Erb; S Howie; S Kontiainen; A Maoz; M Mathies; I McKenzie; J Woody
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

7.  Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.

Authors:  G N Douglas; A S Rubin
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

8.  Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells.

Authors:  A S Rubin; A B MacDonald; A H Coons
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

9.  Phosphofructokinase. Correlation of physical and enzymatic properties.

Authors:  V Paetkau; H A Lardy
Journal:  J Biol Chem       Date:  1967-05-10       Impact factor: 5.157

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.